JP2002114690A - Deodorant for excrement - Google Patents
Deodorant for excrementInfo
- Publication number
- JP2002114690A JP2002114690A JP2000311412A JP2000311412A JP2002114690A JP 2002114690 A JP2002114690 A JP 2002114690A JP 2000311412 A JP2000311412 A JP 2000311412A JP 2000311412 A JP2000311412 A JP 2000311412A JP 2002114690 A JP2002114690 A JP 2002114690A
- Authority
- JP
- Japan
- Prior art keywords
- defecation
- deodorant
- deodorizing
- composition
- odor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002781 deodorant agent Substances 0.000 title claims description 36
- 239000000203 mixture Substances 0.000 claims abstract description 46
- 230000001877 deodorizing effect Effects 0.000 claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 31
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims abstract description 14
- 229920000926 Galactomannan Polymers 0.000 claims abstract description 14
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 11
- 241000186660 Lactobacillus Species 0.000 claims abstract description 8
- 241000194017 Streptococcus Species 0.000 claims abstract description 7
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 7
- 239000000194 fatty acid Substances 0.000 claims abstract description 7
- 229930195729 fatty acid Natural products 0.000 claims abstract description 7
- -1 fatty acid ester Chemical class 0.000 claims abstract description 7
- 241000192132 Leuconostoc Species 0.000 claims abstract description 6
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 6
- 230000013872 defecation Effects 0.000 claims description 46
- 244000269722 Thea sinensis Species 0.000 claims description 35
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 34
- 241000894006 Bacteria Species 0.000 claims description 31
- 239000004310 lactic acid Substances 0.000 claims description 17
- 235000014655 lactic acid Nutrition 0.000 claims description 17
- 229920000223 polyglycerol Polymers 0.000 claims description 4
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 12
- 238000000354 decomposition reaction Methods 0.000 abstract description 4
- 244000144972 livestock Species 0.000 abstract description 3
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 abstract 1
- 235000019645 odor Nutrition 0.000 description 32
- 235000013616 tea Nutrition 0.000 description 30
- 238000012360 testing method Methods 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 18
- 210000003608 fece Anatomy 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 15
- 241000282472 Canis lupus familiaris Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 8
- 239000003925 fat Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000007127 saponification reaction Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229910021536 Zeolite Inorganic materials 0.000 description 6
- 239000003674 animal food additive Substances 0.000 description 6
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 239000010457 zeolite Substances 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 229940092665 tea leaf extract Drugs 0.000 description 5
- 240000002234 Allium sativum Species 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000004611 garlic Nutrition 0.000 description 4
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 235000002949 phytic acid Nutrition 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 241000218645 Cedrus Species 0.000 description 3
- 244000301850 Cupressus sempervirens Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- NCPBIRUAPZPILF-UHFFFAOYSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O NCPBIRUAPZPILF-UHFFFAOYSA-N 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 3
- 241000018646 Pinus brutia Species 0.000 description 3
- 235000011613 Pinus brutia Nutrition 0.000 description 3
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 3
- 230000021736 acetylation Effects 0.000 description 3
- 238000006640 acetylation reaction Methods 0.000 description 3
- 102000038379 digestive enzymes Human genes 0.000 description 3
- 108091007734 digestive enzymes Proteins 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 2
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 2
- 235000004911 (-)-epigallocatechin gallate Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- CSTSVCHPEZPQLA-UHFFFAOYSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O CSTSVCHPEZPQLA-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- VFSWRBJYBQXUTE-UHFFFAOYSA-N epi-Gallocatechin 3-O-gallate Natural products Oc1ccc2C(=O)C(OC(=O)c3cc(O)c(O)c(O)c3)C(Oc2c1)c4cc(O)c(O)c(O)c4 VFSWRBJYBQXUTE-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 150000003272 mannan oligosaccharides Chemical class 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- 229930013783 (-)-epicatechin Natural products 0.000 description 1
- 235000007355 (-)-epicatechin Nutrition 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- KBPZVLXARDTGGD-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;iron Chemical compound [Fe].OC(=O)C(O)C(O)C(O)=O KBPZVLXARDTGGD-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000209507 Camellia Species 0.000 description 1
- 101100301076 Canis lupus familiaris RBM47 gene Proteins 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101000777301 Homo sapiens Uteroglobin Proteins 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241001453382 Nitrosomonadales Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 102100031083 Uteroglobin Human genes 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019730 animal feed additive Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 238000010000 carbonizing Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000019516 cod Nutrition 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 108010066429 galactomannanase Proteins 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- UZIBPBFWHMZFKP-UHFFFAOYSA-N octadecanoic acid propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O UZIBPBFWHMZFKP-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 230000000485 pigmenting effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- YLLIGHVCTUPGEH-UHFFFAOYSA-M potassium;ethanol;hydroxide Chemical compound [OH-].[K+].CCO YLLIGHVCTUPGEH-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、人ならびに牛、
豚、馬および鶏などの産業動物や犬や猫などのペットに
おいて生体に服用させることによりこの生体から排泄さ
れる糞便の臭いを低減する作用を有する排便消臭用組成
物に関する。The present invention relates to humans and cattle,
The present invention relates to a defecation deodorizing composition which has an effect of reducing the smell of feces excreted from living organisms by taking the organism in industrial animals such as pigs, horses and chickens, and pets such as dogs and cats.
【0002】[0002]
【従来の技術】人口のなかで高齢者が相対的に増えてお
り、2015年には国民の4人に1人が65歳以上とい
う高齢化社会の突入が明らかになっている。介護保険も
スタートし、ボケと寝たきりで要介護の人が身近な存在
となるにつれ、介護における排便の臭いが問題となる。
また、若い女性等は自らの排便臭を気にして自宅外では
便意を我慢する傾向がありこれが便秘を招く一因ともな
っている。健康な時の排便の便臭よりも便秘の時の便臭
の方が臭いが臭くなる。一方動物においての悪臭に関し
ては、畜産の悪臭苦情は常に上位に位置しており、牛、
豚、馬、鶏などの産業動物の排泄する糞便や尿の臭いの
低減化は常に望まれている(防脱臭技術集成,24,1
997)。また近年、我が国では高齢人口の増加や核家
族化に伴い、ペットを飼う家族が急増している。ペット
を屋内で飼育される場合が増加しており、飼い主にとっ
てペットの排糞の臭いが問題となっている。悪臭苦情件
数でも「個人住宅・アパート・寮」などのいわゆる都市
・生活型に分類される悪臭苦情の割合が増加している
(防脱臭技術集成,24,1997)。そこで、人にお
いて安全でかつ効果的に糞中の悪臭物質の消臭機能を有
する食品素材および動物用飼料が強く望まれている。2. Description of the Related Art The elderly are relatively increasing in the population, and it has become clear that in 2015, one out of four people will be 65 years old or older, and that an aging society has entered. Nursing care insurance has also started, and as people needing nursing care become more familiar when they are blurred and bedridden, the smell of defecation in nursing care becomes a problem.
In addition, young women tend to endure bowel movements outside their homes due to their defecation odor, which is one of the causes of constipation. Feces smell during constipation is more odorous than defecation stool during healthy defecation. On the other hand, regarding animal odors, animal odor complaints are always at the top of the list, with cattle,
It is always desired to reduce the smell of feces and urine excreted by industrial animals such as pigs, horses, chickens, etc.
997). In recent years, the number of families who keep pets has been rapidly increasing in Japan with the increase in the elderly population and the nuclear family. The number of cases where pets are bred indoors is increasing, and the odor of pet excrement is becoming a problem for owners. As for the number of odor complaints, the proportion of odor complaints classified as so-called urban / life style such as "personal house / apartment / dormitory" is increasing (Anti-odor technology collection, 24, 1997). Therefore, there is a strong demand for food materials and animal feeds that have a function of deodorizing malodorous substances in feces safely and effectively in humans.
【0003】家畜やペットの排便を消臭する素材に関し
ては、特開昭50−18264号公報には好気性及び嫌
気性微生物にビタミン類などの有用物質を添加して糞便
を消臭する飼料添加物が開示されている。また、微生物
を単独で利用した飼料添加物としては、特開平9−32
2714号公報に乳酸球菌、芽胞菌を主成分とし、放線
菌、糸状菌、酵母を添加させることにより排泄糞のアン
モニア臭を低減させ、糞便を1週間放置すると微生物に
より窒素やイオウ化合物の生成が抑制される消臭性飼料
が開示されている。[0003] As for materials for deodorizing the defecation of livestock and pets, Japanese Patent Application Laid-Open No. 50-18264 discloses a feed additive for deodorizing feces by adding useful substances such as vitamins to aerobic and anaerobic microorganisms. Is disclosed. Further, as a feed additive using a microorganism alone, Japanese Patent Application Laid-Open No. 9-32
No. 2714, which contains lactococci and spores as main components, reduces the smell of ammonia in excreted feces by adding actinomycetes, filamentous fungi and yeast, and when feces are left for one week, the formation of nitrogen and sulfur compounds by microorganisms A deodorant feed that is controlled is disclosed.
【0004】更に、特開平9−322714号公報には
アンモニア酸化菌、硝酸菌、イオウ酸化菌及びセルロー
ス分解菌を用いて米糠を主体とする培養基にて発酵させ
た飼料用添加剤が開示されている。Further, Japanese Patent Application Laid-Open No. 9-322714 discloses a feed additive prepared by fermenting a rice bran-based culture medium using ammonia-oxidizing bacteria, nitric acid bacteria, sulfur-oxidizing bacteria and cellulose-decomposing bacteria. I have.
【0005】また、オリゴ糖の脱臭効果については、特
開平9−38184号公報に茶殻、酵母発酵粕又はマン
ナンオリゴ糖から選択した混合物を添加した消臭性飼料
が開示され、茶殻と酵母発酵粕(マンナンオリゴ糖を含
有する)の併用により糞便中のアンモニアガスが低減す
るとされる。Regarding the deodorizing effect of oligosaccharides, Japanese Patent Application Laid-Open No. 9-38184 discloses a deodorizing feed to which a mixture selected from tea husk, yeast fermented lees or mannan oligosaccharide is added. It is said that ammonia gas in feces is reduced by the combined use of (containing mannan oligosaccharide).
【0006】その他の脱臭素材(又は脱臭方法)として
は、悪臭吸着作用をもち、飼料添加素材として認可され
ているゼオライトや消臭作用を有する植物性消臭剤が知
られている。上記のゼオライトの消臭効果については特
開昭58−190358号公報にゼオライトに糖蜜を添
加した飼料添加物が、また特開昭52−47484号公
報には消化酵素産生微生物をゼオライトに吸着させた飼
料添加物が開示されている。後者は消化酵素とゼオライ
トの相乗効果によって、家畜の消化を良好にするととも
に糞便の臭気を低下させるとされている。[0006] As other deodorizing materials (or deodorizing methods), zeolite, which has an odor absorbing effect and is approved as a feed additive material, and a plant deodorant having a deodorizing effect are known. Regarding the deodorizing effect of the above-mentioned zeolite, JP-A-58-190358 discloses that a feed additive obtained by adding molasses to zeolite, and JP-A-52-47484 discloses that a digestive enzyme-producing microorganism is adsorbed by zeolite. Feed additives are disclosed. The latter is said to improve digestion of livestock and reduce fecal odor by the synergistic effect of digestive enzymes and zeolite.
【0007】また、植物性消臭剤としては、特開平5−
336895号公報に、米糠と大豆の枯草菌による発酵
液とニンジン葉の抽出液を原料とした植物性消臭剤が開
示されている。Further, as a vegetable deodorant, Japanese Patent Application Laid-Open No.
No. 336895 discloses a plant deodorant made from a fermented solution of rice bran and soybean with Bacillus subtilis and an extract of carrot leaves.
【0008】特開平11−285348には糞便による
悪臭の産生を抑制する消臭物質と吸着する消臭物質を含
有する動物用飼料添加物および動物用飼料が開示されて
いる。Japanese Patent Application Laid-Open No. 11-285348 discloses an animal feed additive and an animal feed containing a deodorant which suppresses the production of malodor by feces and a deodorant which adsorbs.
【0009】人の排便を消臭する素材に関しては、特開
平10−120574にフィチン酸およびフィチン酸
塩、杉、檜及び松の樹木含有成分液と茶葉抽出液及びマ
ッシュルーム抽出液を含有する糞尿消臭剤が開示されて
いる。With respect to materials for deodorizing human defecation, Japanese Unexamined Patent Application Publication No. 10-120574 discloses a feces urine containing phytic acid and phytate, a component solution containing cedar, cypress and pine trees, a tea leaf extract and a mushroom extract. An odorant is disclosed.
【0010】茶ポリフェノールを人の排便を消臭する目
的に実施した例では、「The Effects of
TeaCatechins on Feacal C
onditions of Elderly Resi
dents in Long−Term Care F
acility」(J.Nutri.Sci.Vita
minol,1999,45,135−141)に35
名のボランティアにより1日当たり300mgの茶カテ
キンを6週間経口摂取させたときの糞便の性状を観察し
ている。[0010] In an example in which tea polyphenols are used for the purpose of deodorizing human defecation, "The Effects of
TeaCatechins on Feacal C
indications of Elderly Resi
dents in Long-Term Care F
facility "(J. Nutri. Sci. Vita
minol, 1999, 45, 135-141) and 35
The nature of feces observed when 300 volunteers orally ingested 300 mg of tea catechin per day for 6 weeks.
【0011】しかし、従来の消臭性素材は、腸内菌叢を
整える作用のある微生物を単独で利用するタイプ、又は
消臭性植物抽出物やゼオライトなどの単一物質を添加す
るタイプか、またはそれぞれの消臭素材を併用して提供
しているがその効果は充分ではなかった。However, the conventional deodorant materials are of a type that uses a microorganism having an action of regulating the intestinal flora alone, or a type that adds a single substance such as a deodorant plant extract or zeolite, Or, they are provided in combination with each deodorant material, but the effect is not sufficient.
【0012】[0012]
【発明が解決しようとする課題】生体に服用させること
により生体から排泄される糞便の臭いを効果的に低減す
る排便消臭用組成物を提供することを目的とする。SUMMARY OF THE INVENTION It is an object of the present invention to provide a defecation deodorizing composition which can effectively reduce the odor of feces excreted from a living body by taking it into the living body.
【0013】[0013]
【課題を解決するための手段】本発明者らは、人および
動物の排便消臭組成物を得ることを目的として、鋭意研
究を重ねた結果、乳酸菌群と、茶抽出物及びガラクトマ
ンナン分解物を含有させることにより上記課題を解決で
きることを見出し、本発明を完成するに至った。すなわ
ち、本発明は、乳酸菌群より選ばれる少なくとも1種類
以上の菌と、茶抽出物及びガラクトマンナン分解物を含
有することを特徴とする排便消臭用組成物である。Means for Solving the Problems The inventors of the present invention have conducted intensive studies with the aim of obtaining a deodorant composition for human and animal defecation. As a result, the group of lactic acid bacteria, tea extract and galactomannan hydrolyzate were decomposed. It has been found that the above-mentioned problems can be solved by incorporating the compound, and the present invention has been completed. That is, the present invention is a defecation deodorant composition comprising at least one or more bacteria selected from the group of lactic acid bacteria, a tea extract and a degraded galactomannan.
【0014】[0014]
【発明の実施の形態】本発明における茶抽出物とは、特
に限定するものではないが、植物学的にはツバキ科の不
発酵茶である緑茶、半発酵茶であるウーロン茶、発酵茶
である紅茶等の抽出物があげられる。好ましくは、消臭
効果の強い緑茶の抽出物を用いるのがよい。茶の抽出方
法は特に限定しないが、茶葉または茶葉を粉末したもの
を、水、温水または熱水にて抽出する方法やメタノー
ル、エタノール、アセトンまたはメチルエチルケトンな
どの有機溶剤にて抽出する方法等があげられる。好まし
くは、ポリフェノールを含む画分であり、更に好ましく
は、(−)エピガロカテキンガレート、(+)カテキ
ン、(−)エピカテキン、(−)エピガロカテキン、
(−)エピカテキンガレートを含む茶抽出物の画分、最
も好ましくは(−)エピガロカテキンガレート、(−)
エピカテキンガレート、(−)エピガロカテキンを含む
茶抽出物の画分を用いるのがよい。茶抽出物に含まれる
カフェインは、大量に摂取すると胸焼けや胃のむかつき
などの症状があらわれるため、好ましくは、カフェイン
を除去した茶抽出画分を用いるのがよい。茶抽出物画分
は製剤化に使用するために溶液の状態で保存できるが、
長期に保存するには噴霧乾燥や凍結乾燥により粉末化し
た方が好ましい。本発明の茶抽出物に含まれるポリフェ
ノール含量は、特に規定するものではないが、通常粉末
重量当たり20%以上であり、好ましくは50%以上、
更に好ましくは70%以上である。茶抽出物に含まれる
ポリフェノールの定量は、没食子酸を標品として、酒石
酸鉄を用いた比色法により測定できる。本発明における
ガラクトマンナン分解物とは、人の消化酵素で消化され
ない難消化性の高分子多糖類であり、ガラクトマンナン
を主成分とするグアーガム、ローカストビーンガム、タ
ラガム等の増粘多糖類を加水分解し、精製、乾燥したも
のである。これらの分解物は、ほとんど無味・無臭で、
しかも、水に無色透明に溶解して低粘度の溶液となる。
この加水分解方法については、酵素による方法、酸によ
る方法等、更に限定するものではないが、酸による方法
では分解がランダムになり単糖類、二糖類等低分子のも
のが生成される場合があり一定の分解がされにくいた
め、酵素による分解が好ましい。酵素分解法に用いられ
る酵素は、マンノース直鎖を加水分解するものであれば
市販のものでも天然由来のものでも更に限定されるもの
ではないが、アスペルギルス属菌やリゾープス属菌等由
来のβ−ガラクトマンナナーゼが好ましい。本発明に使
用されるガラクトマンナン分解物は、1%水溶液をB型
粘度計を用いて測定した時の粘度が10mPa・s以下
であることが望ましい。ガラクトマンナン分解物の平均
分子量は2,000以上が好ましく、更に、糖鎖の平均
分子量として2,000〜100,000である事が望
ましい。更に好ましくは平均分子量として5,000〜
40,000程度に分解したものが取り扱いとして望ま
しい。平均分子量の測定方法は、更に限定するものでは
ないが、ポリエチレングリコール(分子量;2,00
0、20,000、100,000)をマーカーに高速
液体クロマトグラフ法(カラム;YMC−Pack D
iol−120(株)ワイエムシィ社製)を用いて、分
子量分布を測定する方法等を用いることにより求めるこ
とができる。本発明における乳酸菌群とは、牛乳の乳糖
を分解して乳酸に変える菌の総称であり、すなわち乳酸
発酵を起こす細菌である。またその特徴としては、グラ
ム陽性、非運動性の、色素を作らない桿菌または球菌で
ある。使用する乳酸菌の属は特に限定するものではない
が、乳酸桿菌のラクトバチルス属およびビフィドバクテ
リウム属、乳酸球菌のストレプトコッカス属およびロイ
コノストック属を単独または併用して用いるのがよい。
ラクトバチルス属とは好気性のグラム陽性の桿菌であ
り、使用するラクトバチルス属は特に限定するものでは
ないが、ラクトバチルス ブルガリカス、ラクトバチル
ス カゼイ、ラクトバチルス ヘルベリカス及びラクト
バチルス アシドフィーラスを用いるのが好ましい。ビ
フィドバクテリウム属とは、人間の新生児の腸内の細菌
叢を形成する嫌気性のグラム陽性桿菌であり、腸内善細
菌数の90%以上を占めている菌である。1988年に
Tissierにより母乳栄養時の糞便より分離され、
生涯にわたり腸内の健康維持に寄与しているといわれて
いる。使用するビフィドバクテリウム属は特に限定する
ものではないがビフィドバクテリウム アデオロセンテ
ィス、ビフィドバクテリウム ビフィダム、ビフィドバ
クテリウム インファンティス、ビフィドバクテリウム
ロンガム、ビフィドバクテリウム ブレイブを用いる
のが好ましい。ストレプトコッカス属とは、好気性グラ
ム陽性球菌であり、使用するストレプトコッカス属は特
に限定するものではないが、ストレプトコッカス ラク
ティス、ストレプトコッカス クレモリス、ストレプト
コッカス サーモフィーラスを用いるのが好ましい。た
だし、ストレプトコッカス属には病原性を有するストレ
プトコッカス ピロゲネスやストレプトコッカス アガ
ラクティス等があり、これら病原菌は本発明における使
用には適さない。ロイコノストック属とは好気性グラム
陽性球菌であり、使用するロイコノストック属は特に限
定するものではないが、ロイコノストック シトロボナ
ムを用いるのが好ましい。本発明の排便消臭用組成物の
調製法は特に限定するものではないが、溶解/懸濁後・
再粉末する方法が好ましい。本発明における溶解/懸濁
した後、再粉末化する方法については特に限定はしない
が、茶抽出物の溶液又は粉末、ガラクトマンナン及び有
用微生物を水溶液中に溶解/分散させ噴霧乾燥又は凍結
乾燥により粉末化する。なお、この際油脂、乳化剤、澱
粉、デキストリン等を添加することもできる。本発明に
おける、乳酸菌属と、茶抽出物及びガラクトマンナンの
配合割合は、特に限定するものではないが、例えば、ガ
ラクトマンナンは、茶抽出物の乾燥重量100gに対し
て1〜20gであり、好ましくは5〜15gである。乳
酸菌属は茶抽出物の乾燥重量100gに対して、菌数が
1 億菌数以上あればよく、好ましくは10億菌数以
上、更に好ましくは100億菌数以上あると良い。本発
明におけるポリグリセリン脂肪酸エステルは特に限定す
るものでないが、ヘキサステアリン酸ヘキサグリセリ
ン、オクタステアリン酸ヘキサグリセリン、デカステア
リン酸デカグリセリン、デカオレイン酸デカグリセリ
ン、ヘキサステアリン酸ペンタグリセリン等が挙げられ
る。水酸基価70以下のものが好ましく、ヘキサステア
リン酸ヘキサグリセリン、デカステアリン酸デカグリセ
リン、オクタステアリン酸オクタグリセリン等が挙げら
れ、更に好ましくは、ポリグリセリン脂肪酸エステルの
水酸基価15以下のエステルを用いた場合であり、オク
タステアリン酸ヘキサグリセリン等が挙げられる。BEST MODE FOR CARRYING OUT THE INVENTION The tea extract in the present invention is not particularly limited, but botanically includes green tea which is an unfermented tea of the family Camellia, oolong tea which is a semi-fermented tea, and fermented tea. Extracts such as black tea are mentioned. Preferably, an extract of green tea having a strong deodorizing effect is used. The method of extracting tea is not particularly limited, and examples thereof include a method of extracting tea leaves or powdered tea leaves with water, warm water or hot water, and a method of extracting the same with an organic solvent such as methanol, ethanol, acetone or methyl ethyl ketone. Can be Preferably, it is a fraction containing a polyphenol, more preferably (-) epigallocatechin gallate, (+) catechin, (-) epicatechin, (-) epigallocatechin,
Fraction of tea extract containing (-) epicatechin gallate, most preferably (-) epigallocatechin gallate, (-)
It is preferable to use a fraction of a tea extract containing epicatechin gallate and (−) epigallocatechin. Caffeine contained in the tea extract causes symptoms such as heartburn and upset stomach when taken in a large amount. Therefore, it is preferable to use a tea extract fraction from which caffeine has been removed. The tea extract fraction can be stored in solution for use in formulation,
For long-term storage, it is preferable to powderize by spray drying or freeze drying. The polyphenol content contained in the tea extract of the present invention is not particularly limited, but is usually 20% or more per powder weight, preferably 50% or more,
More preferably, it is at least 70%. The quantification of the polyphenol contained in the tea extract can be measured by a colorimetric method using iron tartrate using gallic acid as a sample. The galactomannan hydrolyzate in the present invention is an indigestible high-molecular polysaccharide that is not digested by human digestive enzymes, and hydrolyzes thickening polysaccharides such as guar gum, locust bean gum, and cod gum mainly containing galactomannan. It is decomposed, purified and dried. These decomposition products are almost tasteless and odorless,
Moreover, it dissolves in water in a colorless and transparent manner to form a low-viscosity solution.
The hydrolysis method is not particularly limited, such as a method using an enzyme, a method using an acid, and the like.However, a method using an acid may cause low-molecular-weight monosaccharides, disaccharides, and the like in some cases. Degradation by enzymes is preferred because certain degradation is difficult. The enzyme used in the enzymatic degradation method is not particularly limited as long as it is a commercially available one or a naturally occurring one as long as it hydrolyzes the mannose linear chain, but β-derived from Aspergillus or Rhizopus, etc. Galactomannanase is preferred. The decomposition product of galactomannan used in the present invention desirably has a viscosity of 10 mPa · s or less when a 1% aqueous solution is measured using a B-type viscometer. The average molecular weight of the degraded galactomannan is preferably 2,000 or more, and more preferably, the average molecular weight of the sugar chain is 2,000 to 100,000. More preferably, the average molecular weight is from 5,000 to
What has been decomposed to about 40,000 is desirable for handling. Although the method for measuring the average molecular weight is not particularly limited, polyethylene glycol (molecular weight: 2,000
0, 20,000, 100,000) as markers for high performance liquid chromatography (column: YMC-Pack D).
iol-120 (manufactured by YMC Corp.) and a method of measuring the molecular weight distribution. The lactic acid bacteria group in the present invention is a general term for bacteria that decompose lactose in milk to lactic acid, that is, bacteria that cause lactic acid fermentation. It is also characterized by gram-positive, non-motile, non-pigmenting bacilli or cocci. The genus of the lactic acid bacterium to be used is not particularly limited, but it is preferable to use the lactic acid bacterium Lactobacillus and Bifidobacterium, and the lactic acid bacterium Streptococcus and Leuconostoc, alone or in combination.
Lactobacillus is an aerobic Gram-positive bacterium, and the Lactobacillus genus to be used is not particularly limited, but Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus herbericas and Lactobacillus acidophilus are used. Is preferred. The genus Bifidobacterium is an anaerobic gram-positive bacterium that forms a bacterial flora in the intestine of a newborn human, and is a bacterium that accounts for 90% or more of the number of good intestinal bacteria. In 1988, it was separated from feces during breastfeeding by Tissier,
It is said to contribute to maintaining intestinal health for a lifetime. The genus Bifidobacterium to be used is not particularly limited, but Bifidobacterium adeolocentis, Bifidobacterium bifidum, Bifidobacterium infantis, Bifidobacterium longum, and Bifidobacterium brave are used. Is preferred. The Streptococcus is an aerobic Gram-positive coccus, and the Streptococcus used is not particularly limited, but it is preferable to use Streptococcus lactis, Streptococcus cremoris, or Streptococcus thermophilus. However, Streptococcus includes pathogenic Streptococcus pyogenes and Streptococcus agalactis, and these pathogens are not suitable for use in the present invention. Leuconostoc is an aerobic gram-positive cocci, and the Leuconostoc genus to be used is not particularly limited, but Leuconostoc citrobonam is preferably used. The method for preparing the defecation deodorant composition of the present invention is not particularly limited, but may be prepared after dissolution / suspension.
Re-pulverization is preferred. The method of re-pulverizing after dissolution / suspension in the present invention is not particularly limited, but a solution or powder of tea extract, galactomannan and useful microorganisms are dissolved / dispersed in an aqueous solution and spray-dried or freeze-dried. Powderize. At this time, fats and oils, an emulsifier, starch, dextrin and the like can be added. In the present invention, the mixing ratio of the lactic acid bacteria and the tea extract and galactomannan is not particularly limited. For example, galactomannan is 1 to 20 g with respect to 100 g of the dry weight of the tea extract, and is preferably used. Is 5 to 15 g. The lactic acid bacterium should have at least 100 million bacteria, preferably at least 1 billion bacteria, and more preferably at least 10 billion bacteria per 100 g of dry weight of the tea extract. The polyglycerin fatty acid ester in the present invention is not particularly limited, and examples thereof include hexaglycerin hexastearate, hexaglycerin octastearate, decaglycerin decastearate, decaglycerin decaoleate, and pentaglycerin hexastearate. Those having a hydroxyl value of 70 or less are preferable, and examples thereof include hexaglycerin hexastearate, decaglycerin decaestearate, and octaglycerin octastearate. More preferably, when an ester of a polyglycerol fatty acid ester having a hydroxyl value of 15 or less is used. And hexaglycerin octastearate and the like.
【0015】本発明の水酸基価は以下の方法で求められ
る。ポリグリセリン脂肪酸エステル50mlと無水酢酸
50mlの混合物をアセチル化用フラスコに取り、還流
冷却器を付けて2h煮沸する。混合物を500mlも水
を入れたビーカーに注ぎ、15min煮沸した後、少し
冷却してから水を除去する。500mlの水を再び加
え、2回目の煮沸を行い水を除く。水層がリトマス試験
紙で中性になるまでこの洗浄操作を3回繰り返し行う。
アセチル化物を内容500mlの分液漏斗に移し、20
0mlの熱水(60〜70℃)で2回洗う。水をできる
だけ除き、ビーカーに移し、5gの硫酸ナトリウム(無
水)を加える。適時振りながら約1h放置する。乾燥し
た濾紙で濾過した後(100〜110℃の加熱器の中で
行う)、乾燥器の中で試料を完全に乾燥させる。この
後、アセチル化した試料は透明で光沢がなければならな
い。アセチル化しないものとアセチル化した試料のケン
化価をそれぞれ測定する。ヒドロキシル価は上記で得ら
れたケン化価より、水酸基価=(アセチル化以後のケン
化価−アセチル化以前のケン化価)/(1.000−
0.0075×アセチル化以後のケン化価)で求められ
る(基準油脂分析試験法1996年版、日本油化学会
編、2.3.6)。The hydroxyl value of the present invention is determined by the following method. A mixture of 50 ml of polyglycerol fatty acid ester and 50 ml of acetic anhydride is placed in a flask for acetylation and boiled for 2 hours with a reflux condenser. The mixture is poured into a beaker containing as much as 500 ml of water, boiled for 15 minutes, and then cooled slightly before removing the water. Add again 500 ml of water, boil a second time and remove the water. This washing operation is repeated three times until the aqueous layer becomes neutral with litmus paper.
The acetylated product was transferred to a 500 ml separatory funnel,
Wash twice with 0 ml hot water (60-70 ° C). Remove as much water as possible and transfer to a beaker and add 5 g of sodium sulfate (anhydrous). Leave for about 1 h with proper shaking. After filtration through a dry filter paper (performed in a heater at 100-110 ° C.), the sample is completely dried in a dryer. After this, the acetylated sample must be transparent and glossy. The saponification values of the unacetylated sample and the acetylated sample are measured. The hydroxyl value is calculated based on the saponification value obtained above from the hydroxyl value = (saponification value after acetylation−saponification value before acetylation) / (1.000−
0.0075 x saponification value after acetylation) (Reference Oil and Fat Analysis Test Method, 1996 edition, edited by the Japan Oil Chemists' Society, 2.3.6).
【0016】ここでケン化価は以下の方法で求められ
る。ポリグリセリン脂肪酸エステル1.5〜2.0gを
ケン価用フラスコに正しくはかり取り、これにN/2水
酸化カリウム−エタノール溶液25mlを正しく加え
る。次にフラスコに冷却器をつけ、ときどき振り混ぜな
がら、還流するエタノールの環が冷却器の上端に達しな
いように加熱温度を調節して穏やかに加熱反応させる。
フラスコの内容物を30min沸騰させたのち直ちに冷
却し、内容物が寒天状に固まらないうちに冷却器を外し
て、フェノールフタレイン指示薬を数滴加えN/2塩酸
標準液で滴定する。なお本試験と並行して空試験を行
う。ケン化価=28.05×(空試験のN/2塩酸標準
液使用量(ml)−本試験のN/2塩酸標準液使用量
(ml))×(N/2塩酸標準液の力価)/(試料採取
量(g))にて計算する(基準油脂分析試験法 199
6年版、日本油化学会編、3.3.2)。Here, the saponification value is determined by the following method. 1.5-2.0 g of polyglycerol fatty acid ester is weighed correctly in a flask for a KAN value, and 25 ml of an N / 2 potassium hydroxide-ethanol solution is correctly added thereto. Next, a condenser is attached to the flask, and the mixture is heated and gently heated while adjusting the heating temperature so that the refluxing ethanol ring does not reach the upper end of the condenser.
The contents of the flask are boiled for 30 minutes and then cooled immediately. Before the contents do not solidify into agar, the cooler is removed, a few drops of a phenolphthalein indicator are added, and the mixture is titrated with an N / 2 hydrochloric acid standard solution. A blank test is performed in parallel with this test. Saponification value = 28.05 x (N / 2 hydrochloric acid standard solution used amount (ml) in blank test-N / 2 hydrochloric acid standard solution used amount (ml) in main test) x (titer of N / 2 hydrochloric acid standard solution) ) / (Sampled amount (g)) (Reference fat and oil analysis test method 199)
6th edition, edited by the Japan Oil Chemists' Society, 3.3.2).
【0017】本発明の排便消臭用組成物の1日の摂取量
は、茶抽出物として10mg以上であり、好ましくは5
0mg以上、更に好ましくは100mg以上である。排
便消臭用組成物の1日の摂取回数は先述の茶抽出物の摂
取量を1回に全量、または1日の所要量を数回に分けて
摂取しても良い。以下、実施例により詳細に説明する。The daily intake of the defecation deodorizing composition of the present invention is at least 10 mg, preferably 5 mg, as a tea extract.
0 mg or more, more preferably 100 mg or more. The number of times of daily intake of the defecation deodorizing composition may be the total amount of the tea extract described above at a time, or the required amount per day may be divided into several times. Hereinafter, an embodiment will be described in detail.
【0018】[0018]
【実施例】実施例1 水10kgに対し茶熱水抽出物(商品名:サンフェノン
100S、ポリフェノール含量75%、太陽化学(株)
社製)を200g、グアー豆酵素分解物(商品名:サン
ファイバーR、太陽化学(株)社製)を150gを混合
溶解し、乳酸菌粉末(商品名:乳酸菌末LAC−34
3、菌数:100億/g、森永乳業(株)社製)を25
g、ビフィズス菌粉末(商品名:ビフィズス菌末BB5
36EX、菌数:1500億/g、森永乳業(株)社
製)を25g懸濁させた。その後、直ちに凍結乾燥を行
い排便消臭用組成物を380g得た。EXAMPLE 1 Hot water extract of tea (trade name: Sanphenone 100S, polyphenol content 75%, Taiyo Chemical Co., Ltd.) in 10 kg of water
Lactobacillus powder (trade name: Lactic Acid Bacterium Powder LAC-34) was mixed and dissolved in 150 g of guar bean enzyme decomposed product (trade name: Sun Fiber R, manufactured by Taiyo Kagaku Co., Ltd.).
3. Number of bacteria: 10 billion / g, manufactured by Morinaga Milk Industry Co., Ltd.)
g, bifidobacterium powder (trade name: bifidobacterium powder BB5)
36EX, the number of bacteria: 150 billion / g, manufactured by Morinaga Milk Industry Co., Ltd.) was suspended in an amount of 25 g. Then, it was immediately freeze-dried to obtain 380 g of a defecation deodorizing composition.
【0019】実施例2 ポリグリセリン脂肪酸エステルを用いた排便消臭用組成
物の調製 菜種極度硬化油(融点57℃)480g、ヘキサステア
リン酸ヘキサグリセリン(水酸基価=60、HLB=
4)(太陽化学(株)社製)100gを混合し、加熱溶
解する。縮合リシノレイン酸テトラグリセリン(太陽化
学(株)社製)を20g添加する。湯煎にて温度を65
℃に保ちながらスリーワンモーターを用いて攪拌しなが
ら茶熱水抽出物(商品名:サンフェノン100S、ポリ
フェノール含量75%、太陽化学(株)社製)を200
g、グアー豆酵素分解物(商品名:サンファイバーR、
太陽化学(株)社製)を150gを混合溶解し、乳酸菌
粉末(商品名:乳酸菌末LAC−343、菌数:100
億/g 、森永乳業(株)社製)を25g、ビフィズス
菌粉末(商品名:ビフィズス菌末BB536EX、菌
数:1500億/g、森永乳業(株)社製)を25g添
加し、ノズル式噴霧装置にて20℃に保った室内へ噴霧
し粉末状被覆粒子を981g得た。Example 2 Preparation of Defecation Deodorizing Composition Using Polyglycerin Fatty Acid Ester 480 g of rapeseed extremely hardened oil (melting point 57 ° C.), hexaglycerin hexastearate (hydroxyl value = 60, HLB =
4) 100 g (manufactured by Taiyo Kagaku Co., Ltd.) are mixed and dissolved by heating. 20 g of condensed tetraglycerin ricinoleate (manufactured by Taiyo Kagaku Co., Ltd.) is added. 65 with hot water
The hot water extract (trade name: Sanphenone 100S, polyphenol content: 75%, manufactured by Taiyo Kagaku Co., Ltd.) was stirred for 200 minutes while using a three-one motor while maintaining the temperature at 200 ° C.
g, guar bean enzyme decomposition product (trade name: Sunfiber R,
150 g of Taiyo Kagaku Co., Ltd.) was mixed and dissolved, and lactic acid bacteria powder (trade name: Lactic acid powder LAC-343, number of bacteria: 100)
100 g / g, Morinaga Milk Industry Co., Ltd.) and 25 g of bifidobacterium powder (trade name: Bifidobacterium powder BB536EX, number of bacteria: 150 billion / g, Morinaga Milk Industry Co., Ltd.), 25 g of nozzle type It was sprayed into a room kept at 20 ° C. by a spraying device to obtain 981 g of powdery coated particles.
【0020】実施例3 排便消臭組成物の一例として実施例1を用い打錠を行っ
た。 原料 含量 重量/錠 実施例1 40% 100mg セルロース 52% 130mg シュガーエステル 3% 7.5mg 粉末油脂(サンソフトL−3C:太陽化学(株)社製) 5% 12.5mg 合計 100% 250mgExample 3 Tableting was performed using Example 1 as an example of the defecation deodorant composition. Raw material Content Weight / tablet Example 1 40% 100mg Cellulose 52% 130mg Sugar ester 3% 7.5mg Powdered fat (Sunsoft L-3C: manufactured by Taiyo Chemical Co., Ltd.) 5% 12.5mg Total 100% 250mg
【0021】実施例4 排便消臭組成物の一例として実施例2を用い打錠を行っ
た。 原料 含量 重量/錠 実施例2 40% 100mg セルロース 52% 130mg シュガーエステル 3% 7.5mg 粉末油脂(サンソフトL−3C:太陽化学(株)社製) 5% 12.5mg 合計 100% 250mgExample 4 Tableting was performed using Example 2 as an example of the defecation deodorant composition. Raw material content Weight / tablet Example 2 40% 100 mg Cellulose 52% 130 mg Sugar ester 3% 7.5 mg Powdered fat (Sunsoft L-3C: manufactured by Taiyo Chemical Co., Ltd.) 5% 12.5 mg Total 100% 250 mg
【0022】比較例1 従来の消臭用組成物として、フィチン酸塩、杉、檜及び
松の樹木含有成分液と、茶葉抽出液を含有する排便消臭
用組成剤を調製した。樹木含有成分液(蒸発残留物濃
度;6.5重量%)10重量部及び茶葉抽出液(蒸発残
留物濃度;47重量%)15重量部に、フィチン酸カリ
ウム100重量部を溶解して混合液とした。ここで用い
た樹木含有成分液は、杉、檜及び松のほぼ等容量のチッ
プを120〜180℃にて数10時間乾留し、その後1
00〜120℃程度にて蒸留(常圧若しくは減圧下)し
て主としてタール分を除去し、必要に応じて水で希釈し
て得たものである。この樹木含有成分液のpHは6〜
7、色調は無色、淡黄色又は淡褐色であり、僅かな香味
があった。また、ここで用いた茶葉抽出物は、緑茶の葉
を水とエタノールとの混合溶媒により抽出して得られた
ものであり、その比重は約1.08であった。上記混合
液に賦形剤を添加し、スプレードライにより粉末化し
た。賦形剤の配合は、以下に示した。また、スプレード
ライにて粉末化したものを一錠300mgとなるように
打錠を行った。 原料 含量 重量/錠 混合液 33% 100mg セルロース 52% 156mg シュガーエステル 15% 45mg 合計 100% 300mgComparative Example 1 As a conventional deodorant composition, a defecation deodorant composition containing phytate, cedar, cypress, and pine tree-containing components and a tea leaf extract was prepared. 100 parts by weight of potassium phytate is dissolved in 10 parts by weight of a tree-containing component liquid (evaporation residue concentration: 6.5% by weight) and 15 parts by weight of tea leaf extract (evaporation residue concentration: 47% by weight). And The tree-containing component liquid used here was obtained by carbonizing almost equal volumes of chips of cedar, cypress and pine at 120 to 180 ° C. for several tens of hours, and then 1
It is obtained by distilling (at normal pressure or reduced pressure) at about 00 to 120 ° C. to mainly remove tar components and, if necessary, diluting with water. The pH of the tree-containing component solution is 6 to
7. The color tone was colorless, pale yellow or pale brown, and had a slight flavor. The tea leaf extract used here was obtained by extracting green tea leaves with a mixed solvent of water and ethanol, and had a specific gravity of about 1.08. An excipient was added to the above mixture, and powdered by spray drying. Excipient formulations are shown below. Further, the powdered product by spray drying was tableted so as to be 300 mg per tablet. Raw material content Weight / tablet Mixed liquid 33% 100mg Cellulose 52% 156mg Sugar ester 15% 45mg Total 100% 300mg
【0023】比較例2 従来の消臭用組成物として、茶葉抽出液をを調製した。
茶殻1.4 kgを粉砕したものをステンレスビーカー
にいれ、熱水3kgを添加し95℃にて30分間抽出を
行った。抽出液は、ろ布によりろ過を行い、更にろ紙
(アドバンテック社製、No.2)にてろ過を行い茶抽
出液を2.4kg得た。茶抽出液はスプレードライヤー
にて乾燥を行い、茶抽出物0.8kgを得た。排便消臭
組成物の一例として比較例2を用い打錠を行った。 原料 含量 重量/錠 比較例2の茶抽出物 20% 50mg セルロース 72% 180mg シュガーエステル 3% 7.5mg 粉末油脂(サンソフトL−3C:太陽化学(株)社製) 5% 12.5mg 合計 100% 250mgComparative Example 2 A tea leaf extract was prepared as a conventional deodorant composition.
A crushed product of 1.4 kg of tea husks was put in a stainless beaker, 3 kg of hot water was added, and extraction was performed at 95 ° C. for 30 minutes. The extract was filtered through a filter cloth and further filtered through a filter paper (No. 2 manufactured by Advantech Co., Ltd.) to obtain 2.4 kg of a tea extract. The tea extract was dried with a spray drier to obtain 0.8 kg of a tea extract. Tableting was performed using Comparative Example 2 as an example of the defecation deodorant composition. Raw material content Weight / tablet Tea extract of Comparative Example 2 20% 50 mg Cellulose 72% 180 mg Sugar ester 3% 7.5 mg Powdered fat (Sunsoft L-3C: manufactured by Taiyo Kagaku Co., Ltd.) 5% 12.5 mg Total 100 % 250mg
【0024】比較例3 対照として以下の処方にて打錠を行った。 原料 含量 重量/錠 セルロース 92% 180mg シュガーエステル 3% 7.5mg 粉末油脂(サンソフトL−3C:太陽化学(株)社製) 5% 12.5mg 合計 100% 250mgComparative Example 3 As a control, tableting was performed according to the following formulation. Raw material Content Weight / tablet Cellulose 92% 180mg Sugar ester 3% 7.5mg Powdered fat (Sunsoft L-3C: manufactured by Taiyo Kagaku Co., Ltd.) 5% 12.5mg Total 100% 250mg
【0025】試験例1 ヒトにおける排便消臭組成物の効果 実施例3、4及び比較例1、2、3にて調製した打錠剤
による排便消臭の比較試験を行った。試験方法被験者と
しては、同じ食事を取っている学生寮生活者を用いた。
学生寮生活者40人を8人づつ5つのグループに分け
た。 1. 無試験期間(7日間) この第1クールでは、通常の食事をとってもらった。 2.第1クール(7日間) 食事とは別に焼ニンニク3個/日を7日間連続して与え
た。 3.第2クール(7日間) 引き続いて、食事と焼ニンニク3個/日を7日間連続し
て与え、更に実施例3、4及び比較例1、2、3の打錠
剤を1日当たり4錠与えた。対照は消臭用組成物は与え
なかった。 4.第3クール(7日間) 実施例3、4及び比較例1、2、3の打錠剤を与えるこ
とを中止し、焼ニンニク3個/日は引き続き7日間連続
して与えた。Test Example 1 Effect of Defecation Deodorizing Composition in Human Comparative tests of defecation deodorization using the tablets prepared in Examples 3 and 4 and Comparative Examples 1, 2 and 3 were conducted. Test method As test subjects, dormitory residents who had the same meal were used.
Forty dormitory residents were divided into five groups of eight. 1. No test period (7 days) In this first course, we had regular meals. 2. First course (7 days) Separately from the meal, 3 baked garlics / day were given for 7 consecutive days. 3. Second course (7 days) Subsequently, a meal and 3 pieces of baked garlic were given continuously for 7 days, and 4 tablets per day of Examples 3, 4 and Comparative Examples 1, 2, and 3 were given. . The control did not receive the deodorant composition. 4. Third Cool (7 days) The tableting of Examples 3, 4 and Comparative Examples 1, 2, and 3 was stopped, and baked garlic was continuously given for 3 consecutive days for 3 days.
【0026】臭気の評価は、各試験者が臭いを官能評価
することにより行い、「1」;やっと感知できる臭い、
「2」;臭いの種類を判定できる程度の臭い、「3」;
よく感知できる臭い、「4」;強い臭い、「5」;強烈
な臭い、として点数化した。The evaluation of the odor is performed by each tester by sensory evaluation of the odor, and "1";
“2”; smell enough to determine the type of smell, “3”;
It was scored as an easily perceivable odor, "4"; a strong odor, "5"; an intense odor.
【0027】無試験期間、第1クール、第2クールおよ
び第3クールにおける実施例3、4及び比較例1、2、
3で作成した打錠品を与えた群の被験者の排便の臭気を
まとめた。臭気の点数は、各被験者の7日間の臭気のポ
イントの合計を平均した(平均値±S.D.)。試験結
果を表1に示す。Examples 3 and 4 and Comparative Examples 1 and 2 in the first test, the second test and the third test during the non-test period.
The odor of defecation of the test subjects in the group receiving the tablet product prepared in 3 was summarized. The score of the odor was obtained by averaging the sum of the odor points of each subject for 7 days (mean ± SD). Table 1 shows the test results.
【0028】[0028]
【表1】 [Table 1]
【0029】表1に示すように、無試験期間に比べ、ニ
ンニクを摂取している第1クール期間は排便消臭の点数
は高くなった。排便消臭効果のある成分を含んだ打錠品
を摂取した第2クールにおいて、排便臭気点数は減少し
た。実施例3、4の打錠品投与群においては、従来品の
比較例1、2の打錠品に比較し排便臭気点数は減少し
た。実施例3の打錠品と4の打錠品を比較すると乳化剤
を併用した実施例4の打錠品はより排便消臭効果が高か
った。また、打錠品の摂取を中止した第3クールにおい
ては、再び排便消臭点数が増加することから、排便消臭
効果は実施例の排便消臭用組成物を摂取することにより
効果があらわれたと推察された。As shown in Table 1, the score of deodorant defecation was higher during the first cool period in which garlic was taken than in the non-test period. In the second course, in which a tablet containing a deodorant deodorant component was ingested, the deodorant odor score decreased. In the tableted product administration groups of Examples 3 and 4, the defecation odor score was reduced as compared with the tableted products of Comparative Examples 1 and 2 of the conventional product. When the tableted product of Example 3 and the tableted product of Example 4 were compared, the tableted product of Example 4 using an emulsifier was more effective in defecation deodorization. In addition, in the third course in which the ingestion of the tableted product was stopped, the defecation deodorizing score increased again, so that the defecation deodorizing effect was obtained by ingesting the defecation deodorizing composition of Example. It was speculated.
【0030】試験例2 動物における排便消臭組成物の効果 本発明の排便消臭用組成物の内服による犬の糞便消臭効
果を調べた。本試験例では、糞便に含まれる代表的な悪
臭成分である硫化水素、メチルメルカプタン及びトリメ
チルアミンの発生量を測定することにより、その消臭効
果を評価した。Test Example 2 Effect of Defecation Deodorizing Composition in Animals The defecation deodorizing effect of dogs by using the defecation deodorizing composition of the present invention was examined. In this test example, the deodorizing effect was evaluated by measuring the amounts of hydrogen sulfide, methyl mercaptan and trimethylamine, which are typical malodorous components contained in feces.
【0031】評価 試験方法 被験体としては、健康と診断された、平均年齢5歳、平
均体重10Kgの犬(Beagle種)5頭を用いた。
それぞれの犬には実施例1、2及び比較例1、2の排便
消臭用組成物を飼料中(SCIENCE DIET、1
60g/日、日本ヒルズ・コルゲート(株))に混合す
ることにより、一日一回それぞれ排便消臭用組成物を7
日間連続して与えた。実施例1、2及び比較例1、2の
排便消臭用組成物を一日当たり300mgを投与した。
また、残りの1頭は対照犬とし、飼料のみを与えた。
尚、水は自由飲水とした。そして、その間毎日糞便を採
集し、ガス検知管及びニオイセンサーを用いて糞便臭の
強度を測定した。尚、各試料とも犬に完全に摂取でき、
また給与期間中は被験犬のいずれも軟便及び下痢便は認
められず全て普通便であった。Evaluation Test Method Five dogs (Beagle breeds) diagnosed as healthy and having an average age of 5 years and an average weight of 10 kg were used as subjects.
Each dog was fed the defecation deodorizing compositions of Examples 1 and 2 and Comparative Examples 1 and 2 in the feed (SCIENCE DIET, 1
60 g / day, mixed with Nippon Hills Colgate Co., Ltd.) to give the defecation deodorant composition once a day for 7 days each.
Given consecutive days. 300 mg of the defecation deodorizing compositions of Examples 1 and 2 and Comparative Examples 1 and 2 were administered per day.
The other one was a control dog and received only feed.
In addition, water was free drinking water. During that time, feces were collected every day, and the intensity of fecal odor was measured using a gas detection tube and an odor sensor. In addition, each sample can be completely consumed by dogs,
During the feeding period, none of the test dogs showed loose stool or diarrhea stool, and all were normal stools.
【0032】評価方法 採集した糞便を冷凍保存し、7日間の試験終了後にまと
めて評価した。室温25℃、湿度60%の試験室におい
て、各糞便10gを秤量して容積150mlのガラス瓶
に入れ、40℃の乾燥器中に約60分間放置して糞便の
温度を約30℃に上昇させた。そして、直読式ガス検知
管(ガステック株式会社製)を用いて、ガラス瓶中にお
ける硫化水素及びメチルメルカプタンの濃度を測定し
た。更に、臭いセンサー(商品名「FRAGRACE
SENSOR SF−105」相互薬工株式会社製)を
用いて、乾燥器より取り出してから10分後の臭気を測
定した。尚、この「臭いセンサー」は、水晶振動子上の
合成二分子被膜に臭いの分子を吸着させ、これにより生
ずる振動数(Hz)の変化により臭いの強さを測定する
ものであって、振動数が高いほど臭いが強いことを示
す。Evaluation method The collected feces were stored frozen and evaluated collectively after the completion of the test for 7 days. In a test room at a room temperature of 25 ° C. and a humidity of 60%, 10 g of each stool was weighed and placed in a glass bottle having a volume of 150 ml, and left in a dryer at 40 ° C. for about 60 minutes to raise the temperature of the stool to about 30 ° C. . Then, the concentration of hydrogen sulfide and methyl mercaptan in the glass bottle was measured using a direct reading gas detector tube (manufactured by Gastech Co., Ltd.). Furthermore, an odor sensor (trade name "FRAGRACE"
Using SENSOR SF-105 (manufactured by Mutual Pharmaceutical Co., Ltd.), the odor was measured 10 minutes after being taken out of the dryer. The "odor sensor" is a device for adsorbing odor molecules on a synthetic bilayer film on a quartz oscillator and measuring the intensity of the odor by a change in frequency (Hz) caused by the adsorption. The higher the number, the stronger the odor.
【0033】試験結果 各被験体について、硫化水素及びメチルメルカプタンの
濃度をそれぞれ表2、3及び4に示す。Test Results The concentrations of hydrogen sulfide and methyl mercaptan are shown in Tables 2, 3 and 4 for each subject.
【0034】[0034]
【表2】 [Table 2]
【0035】[0035]
【表3】 [Table 3]
【0036】[0036]
【表4】 [Table 4]
【0037】表2〜表4より、実施例1、2の排便消臭
用組成物を与えた犬では、給与開始から2日目以降は硫
化水素及びメチルメルカプタンのいずれも対照の犬に比
べて低減していることがわかる。これは、表5に示す臭
いセンサーの測定値からも明らかである。また、比較例
1、2の排便消臭用組成物を与えた比較犬と実施例1、
2の排便消臭用組成物との比較から判るように、比較例
1、2の排便消臭用組成物においても消臭効果は見られ
るが、実施例1、2の排便消臭用組成物に対してその効
果の発現は遅く消臭能力も低い。この結果から、乳酸菌
群と、茶抽出物及びガラクトマンナン分解物を併用し、
更に乳化剤を用いて製剤化することにより、より高い消
臭能力が得られることが判る。As shown in Tables 2 to 4, in the dogs to which the defecation deodorizing compositions of Examples 1 and 2 were given, both of hydrogen sulfide and methyl mercaptan were compared to the control dogs on and after the second day from the start of feeding. It can be seen that it has been reduced. This is clear from the measured values of the odor sensor shown in Table 5. In addition, the comparative dogs provided with the defecation deodorizing compositions of Comparative Examples 1 and 2 and Example 1,
As can be seen from the comparison with the defecation deodorant composition of Comparative Example 2 and Comparative Example 1, the deodorant deodorant compositions of Comparative Examples 1 and 2 show the deodorant effect, but the defecation deodorant compositions of Examples 1 and 2. On the other hand, the effect is late onset and the deodorizing ability is low. From this result, lactic acid bacteria group, tea extract and galactomannan hydrolyzate in combination,
Further, it is understood that a higher deodorizing ability can be obtained by formulating the composition using an emulsifier.
【0038】尚、本発明においては、上記具体的実施例
に示すものに限られず、目的、用途に応じて本発明の範
囲内で種々変更した実施例とすることができる。It should be noted that the present invention is not limited to the specific embodiments described above, but can be variously modified within the scope of the present invention in accordance with the purpose and application.
【0039】[0039]
【発明の効果】本発明の排便消臭用組成物は、人及び動
物のいずれに対しても、その糞便に対して優れた消臭効
果を有する。従って、屋内で猫等のペットを飼育しても
部屋が悪臭で充満することがない。また、老人医療や病
人看護等の分野において、おむつ等を使用している患者
の糞尿臭を低減することができるので、従来は我慢を強
いられていた介護人の負担を軽減することができる。更
に、若い女性等は自らの排便臭を気にして自宅外では便
意を我慢する傾向にありこれが便秘を招く一因ともなっ
ているが、本発明の糞尿消臭剤を服用することにより排
便臭を低減することができるので、便秘を解消して美容
及び健康を保つ効果がある。The defecation deodorizing composition of the present invention has an excellent deodorizing effect on feces of both humans and animals. Therefore, even if a pet such as a cat is bred indoors, the room will not be filled with odor. In addition, in fields such as geriatric medicine and sick patient nursing, the urine smell of patients using diapers and the like can be reduced, so that the burden on caregivers who have conventionally been forced to endure can be reduced. Furthermore, young women, etc. tend to endure bowel movements outside their homes due to their defecation odor, which is one of the causes of constipation.However, by taking the excrement deodorant of the present invention, defecation odor is reduced. Since it can be reduced, there is an effect of eliminating constipation and maintaining beauty and health.
【0040】また、服用等させることにより消臭効果を
発揮するため、排泄前の状態で糞の悪臭発生を防止でき
る。従って、悪臭成分の大気中への揮散が少ないので消
臭効果に優れる。また、動物用として使用する場合に
は、従来の消臭剤とは異なり猫等が所定の決まった場所
で便をしないときにも消臭することができるし、取扱い
の困難な猫砂等を用いる必要もない。更に、本消臭剤に
おいては、植物抽出液を用い固形物を除去しているの
で、有効成分濃度が高くその品質に優れると共に、動物
に対して使用する場合には容易にペットフード等に混合
することができる。In addition, since the deodorizing effect is exhibited by taking the product, it is possible to prevent the generation of offensive odor of feces before excretion. Therefore, the odorous component is less volatilized into the atmosphere, and thus has an excellent deodorizing effect. Also, when used for animals, unlike conventional deodorants, it can deodorize even when cats etc. do not stool at predetermined fixed places, and can remove cat sand etc. which are difficult to handle. No need to use. Furthermore, this deodorant uses plant extracts to remove solids, so the active ingredient concentration is high and its quality is excellent, and when used on animals, it can be easily mixed with pet food. can do.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 43/00 A61P 43/00 171 171 Fターム(参考) 4C076 AA42 CC16 CC50 DD46 FF21 GG06 GG32 4C086 AA01 AA02 EA20 NA05 NA14 ZA66 ZC61 ZC75 ZC80 4C087 AA01 AA02 BC56 BC59 BC61 BC75 MA02 MA05 NA05 NA14 ZA66 ZC61 ZC75 ZC80 4C088 AB45 AC05 BA08 CA05 CA06 CA07 MA04 MA52 NA05 NA14 ZA66 ZC61 ZC75 ZC80 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI theme coat ゛ (reference) A61P 43/00 A61P 43/00 171 171 F term (reference) 4C076 AA42 CC16 CC50 DD46 FF21 GG06 GG32 4C086 AA01 AA02 EA20 NA05 NA14 ZA66 ZC61 ZC75 ZC80 4C087 AA01 AA02 BC56 BC59 BC61 BC75 MA02 MA05 NA05 NA14 ZA66 ZC61 ZC75 ZC80 4C088 AB45 AC45 BA08 CA05 CA06 CA07 MA04 MA52 NA05 NA14 ZA66 ZC61 ZC75 ZC80
Claims (4)
以上の菌と、茶抽出物及びガラクトマンナン分解物を含
有することを特徴とする排便消臭用組成物。1. A defecation deodorizing composition comprising at least one or more bacteria selected from the group of lactic acid bacteria, a tea extract and a degraded galactomannan.
以上の菌と、茶抽出物、ガラクトマンナン分解物及びポ
リグリセリン脂肪酸エステルを含有することを特徴とす
る排便消臭用組成物。2. A defecation deodorant composition comprising at least one or more bacteria selected from the group of lactic acid bacteria, a tea extract, a degraded galactomannan, and a polyglycerol fatty acid ester.
素分解物である請求項1または2記載の排便消臭用組成
物。3. The defecation deodorant composition according to claim 1, wherein the galactomannan hydrolyzate is a guar gum enzymatic hydrolyzate.
トコッカス属、ロイコノストック属、ビフィドバクテリ
ウム属からなる群より選ばれる少なくとも1種類以上で
ある請求項1〜3いずれか記載の排便消臭用組成物。4. The defecation deodorant according to claim 1, wherein the lactic acid bacteria group is at least one selected from the group consisting of Lactobacillus, Streptococcus, Leuconostoc, and Bifidobacterium. Composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000311412A JP2002114690A (en) | 2000-10-12 | 2000-10-12 | Deodorant for excrement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000311412A JP2002114690A (en) | 2000-10-12 | 2000-10-12 | Deodorant for excrement |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002114690A true JP2002114690A (en) | 2002-04-16 |
Family
ID=18791178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000311412A Pending JP2002114690A (en) | 2000-10-12 | 2000-10-12 | Deodorant for excrement |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002114690A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007122803A1 (en) * | 2006-04-18 | 2007-11-01 | Taiyo Kagaku Co., Ltd. | Process for producing product of enzymatic galactomannan decomposition, food or beverage, and feed |
JP2010148374A (en) * | 2008-12-24 | 2010-07-08 | Katsunori Sunagawa | Food material using okinawan millet brandy distilled and squeezed lee, and apparatus for deodorizing the okinawan millet brandy distilled and squeezed lee |
US8623434B2 (en) | 2003-12-19 | 2014-01-07 | Fuji Chemical Industry Co., Ltd. | Astaxanthin-containing pet foods |
JP7208140B2 (en) | 2016-12-16 | 2023-01-18 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | pet food composition |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05246859A (en) * | 1992-03-03 | 1993-09-24 | Taiyo Kagaku Co Ltd | Intestinal situation improver with enzymatic degradation product of gum guaiac as active ingredient |
JPH06225734A (en) * | 1993-02-05 | 1994-08-16 | Taiyo Kagaku Co Ltd | Functional powdery beverage and its production |
JPH06233807A (en) * | 1993-02-05 | 1994-08-23 | Taiyo Kagaku Co Ltd | Fecal malodor reducing composition |
JPH06256180A (en) * | 1993-03-04 | 1994-09-13 | Taiyo Kagaku Co Ltd | Enteric environment-improving composition |
JPH06329548A (en) * | 1993-05-19 | 1994-11-29 | Taiyo Kagaku Co Ltd | Preventing and therapeutic agent for diarrhea in livestock or the like |
JPH0899884A (en) * | 1994-09-29 | 1996-04-16 | Taiyo Kagaku Co Ltd | Suppressant for proliferation of gram-negative bacterium |
JPH11285348A (en) * | 1998-04-04 | 1999-10-19 | Nippon Meat Packers Inc | Additive for forage for animal and the same forage |
-
2000
- 2000-10-12 JP JP2000311412A patent/JP2002114690A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05246859A (en) * | 1992-03-03 | 1993-09-24 | Taiyo Kagaku Co Ltd | Intestinal situation improver with enzymatic degradation product of gum guaiac as active ingredient |
JPH06225734A (en) * | 1993-02-05 | 1994-08-16 | Taiyo Kagaku Co Ltd | Functional powdery beverage and its production |
JPH06233807A (en) * | 1993-02-05 | 1994-08-23 | Taiyo Kagaku Co Ltd | Fecal malodor reducing composition |
JPH06256180A (en) * | 1993-03-04 | 1994-09-13 | Taiyo Kagaku Co Ltd | Enteric environment-improving composition |
JPH06329548A (en) * | 1993-05-19 | 1994-11-29 | Taiyo Kagaku Co Ltd | Preventing and therapeutic agent for diarrhea in livestock or the like |
JPH0899884A (en) * | 1994-09-29 | 1996-04-16 | Taiyo Kagaku Co Ltd | Suppressant for proliferation of gram-negative bacterium |
JPH11285348A (en) * | 1998-04-04 | 1999-10-19 | Nippon Meat Packers Inc | Additive for forage for animal and the same forage |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8623434B2 (en) | 2003-12-19 | 2014-01-07 | Fuji Chemical Industry Co., Ltd. | Astaxanthin-containing pet foods |
US9820497B2 (en) | 2003-12-19 | 2017-11-21 | Fuji Chemical Industry Co., Ltd. | Astaxanthin-containing pet foods |
WO2007122803A1 (en) * | 2006-04-18 | 2007-11-01 | Taiyo Kagaku Co., Ltd. | Process for producing product of enzymatic galactomannan decomposition, food or beverage, and feed |
JP2010148374A (en) * | 2008-12-24 | 2010-07-08 | Katsunori Sunagawa | Food material using okinawan millet brandy distilled and squeezed lee, and apparatus for deodorizing the okinawan millet brandy distilled and squeezed lee |
JP7208140B2 (en) | 2016-12-16 | 2023-01-18 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | pet food composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Matthies et al. | Daidzein and Genistein Are Converted to Equol and 5-Hydroxy-Equol by Human Intestinal Slackia isoflavoniconvertens in Gnotobiotic Rats3 | |
JP6462887B2 (en) | A drinking agent and a feed composition having a function of removing malodor from pet urine, comprising a mixture of natural extracts as an active ingredient | |
DE69919953T2 (en) | FUNCTIONAL COMPOSITIONS | |
CA2433484C (en) | Composition for use in animal nutrition comprising a controlled release lipid matrix, method for preparing the composition and method for the treatment of monogastric animals | |
CN101095698A (en) | Probiotics and prebiotics for preventing and treating foetid faeces and foetid faeces poisoning syndrome and the composition preparations thereof | |
Muhl et al. | Growth and parameters of microflora in intestinal and faecal samples of piglets due to application of a phytogenic feed additive | |
JP2011024583A (en) | Pet food composition for treating helicobacter species in pet | |
CN101155518A (en) | Pet food compositions comprising two components | |
Harris et al. | Nutritional tips for veterinarians | |
JP5592640B2 (en) | Antistress agent containing lactic acid bacteria fermented royal jelly, method for producing the same, hypothalamus-pituitary-adrenocortical activity inhibitor, and sympathetic-adrenal medullary activity inhibitor | |
AU620874B2 (en) | Composition obtained from rice bran and use thereof | |
JPH11285348A (en) | Additive for forage for animal and the same forage | |
KR102182093B1 (en) | Oral composition comprising graviola mixed powder easy to take | |
MXPA03000359A (en) | Dietary lipids for improving skin and coat of pets. | |
JP2009057284A (en) | Microbial preparation for reducing greenhouse effect gas excreted from livestock or fowl | |
JPS63266A (en) | Method for improving animal smell | |
CN104719618A (en) | Composite deodorant and preparation method and application thereof | |
WO1997045023A1 (en) | Vegetable deodorant for feces and urine | |
AU1476402A (en) | Sorbic acid product as addition to feedstuffs in agricultural livestock rearing | |
JP2002114690A (en) | Deodorant for excrement | |
JP3987177B2 (en) | Deodorization method for livestock excrement, food and feed additive for deodorizing animal excrement | |
CN107647397A (en) | A kind of probiotic powder and preparation method thereof | |
JP2011045251A (en) | Lactic acid fermented feed and method for producing the same | |
JP2007001900A (en) | Tryptophanase inhibitor and composition containing the inhibitor | |
Sudha et al. | SAFETY STUDIES OF BACILLUS COAGULANS Unique IS-2 IN RATS: MORPHOLOGICAL, BIOCHEMICAL AND CLINICAL EVALUATIONS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071009 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101224 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110222 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110318 |